LAUREN PEPE: Open Payments
NPI 1871251181 · ALDIE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 26 payments from 12 companies in 2025. Trend: 2023 $144 · 2024 $995 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $233 |
| Novo Nordisk Inc | 2 | $104 |
| Lilly USA, LLC | 3 | $68 |
| PFIZER INC. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Hologic Sales and Service, LLC | 1 | $30 |
| Astellas Pharma US Inc | 1 | $27 |
| Optinose US, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: REPATHA, OTEZLA, Rybelsus, MOUNJARO, NURTEC ODT, CAPLYTA, APTIMA, Veozah.
Industry payments across VA — which companies pay providers there.
